Healthcare -
Biotechnology - NASDAQ - CH
$ 5.555
-0.626 %
$ 205 M
Market Cap
-2.68
P/E
MOLN - STOCK-BASED COMPENSATION
Stock-based Compensation MOLN - Molecular Partners AG
5.21 M
LAST VALUE
12.90%
2 YEAR CAGR
6.98%
5 YEAR CAGR
20.13%
10 YEAR CAGR